Page last updated: 2024-10-16

gamma-aminobutyric acid and Autosomal Dominant Hereditary Spastic Paraplegia

gamma-aminobutyric acid has been researched along with Autosomal Dominant Hereditary Spastic Paraplegia in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research Excerpts

ExcerptRelevanceReference
"Patients with hereditary spastic paraplegia (HSP) are often treated with antispastic drugs to relieve symptoms but documentation is lacking."2.73Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia. ( Fenger, K; Jennum, P; Nielsen, JE; Rogvi-Hansen, Bá; Scheuer, KH; Svenstrup, K; Werdelin, L, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scheuer, KH1
Svenstrup, K1
Jennum, P1
Rogvi-Hansen, Bá1
Werdelin, L1
Fenger, K1
Nielsen, JE1

Trials

1 trial available for gamma-aminobutyric acid and Autosomal Dominant Hereditary Spastic Paraplegia

ArticleYear
Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia.
    European journal of neurology, 2007, Volume: 14, Issue:6

    Topics: Adenosine Triphosphatases; Adult; Aged; Amines; Anticonvulsants; Cross-Over Studies; Cyclohexanecarb

2007